ADVERTISEMENT

Brionna Mendoza

The US Food and Drug Administration headquarters sign.

FDA Approves Donanemab for Early Alzheimer Disease Treatment

07/02/2024

Brionna Mendoza ;

The US Food and Drug Administration has issued a highly-anticipated decision: the approval of donanemab—to be marketed as Kisunla by manufacturer Eli Lilly—for the treatment of early Alzheimer disease.

The US Food and Drug Administration has issued a highly-anticipated decision: the approval of donanemab—to be marketed as Kisunla by manufacturer Eli Lilly—for the treatment of early Alzheimer disease.

The US Food and Drug...

07/02/2024

Psych Congress Network

The US Food and Drug Administration headquarters sign.

News

FDA Rejects Parkinson Drug Due to 3rd-Party Manufacturing Concerns

07/02/2024

Brionna Mendoza ;

The US Food and Drug Administration (FDA) rejected AbbVie’s ABBV-95 (foscarbidopa/foslevodopa) last week, raising concerns via complete response letter (CRL) regarding the inspection of a third-party manufacturer listed in the drug...

The US Food and Drug Administration (FDA) rejected AbbVie’s ABBV-95 (foscarbidopa/foslevodopa) last week, raising concerns via complete response letter (CRL) regarding the inspection of a third-party manufacturer listed in the drug...

The US Food and Drug...

07/02/2024

Neurology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

July 18 ⁠–⁠ July 19

July 19 ⁠–⁠ July 20

July 24 ⁠–⁠ July 26

July 26 ⁠–⁠ July 27

July 27 ⁠–⁠ July 28

July 27 ⁠–⁠ July 28

August 8 ⁠–⁠ August 9

August 14 ⁠–⁠ August 17

August 16 ⁠–⁠ August 17

August 16 ⁠–⁠ August 18

See Full Calendar

Advertisement

Advertisement